Daniel Aliseda

787 total citations
29 papers, 425 citations indexed

About

Daniel Aliseda is a scholar working on Surgery, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Aliseda has authored 29 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 9 papers in Ophthalmology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Aliseda's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Daniel Aliseda is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Daniel Aliseda collaborates with scholars based in Spain, Canada and Italy. Daniel Aliseda's co-authors include Javier Moreno‐Montañés, Alfredo García‐Layana, Miguel J. Maldonado, Fernando Rotellar, Luís Serrano, Gabriel Zozaya, Pablo Martí‐Cruchaga, Idoia Gaminde, Bruno Sangro and Mercedes Iñarrairaegui and has published in prestigious journals such as Hepatology, Annals of Surgery and Ophthalmology.

In The Last Decade

Daniel Aliseda

26 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Aliseda Spain 12 285 270 80 70 38 29 425
Jin‐Hyoung Kim South Korea 13 195 0.7× 167 0.6× 94 1.2× 92 1.3× 43 1.1× 20 352
Gábor Tóth Hungary 13 262 0.9× 272 1.0× 76 0.9× 84 1.2× 78 2.1× 50 490
Errol W. Chan Singapore 12 224 0.8× 344 1.3× 16 0.2× 99 1.4× 13 0.3× 23 398
María José Cosentino Italy 11 360 1.3× 273 1.0× 30 0.4× 198 2.8× 86 2.3× 25 451
Ahmed Abdelrahman Egypt 8 190 0.7× 168 0.6× 45 0.6× 30 0.4× 48 1.3× 46 431
Rosario Cobo-Soriano Spain 12 318 1.1× 388 1.4× 15 0.2× 157 2.2× 101 2.7× 34 498
Aakriti Gupta Australia 6 49 0.2× 62 0.2× 35 0.4× 60 0.9× 7 0.2× 8 358
Evelyne C. C. Cauberg Netherlands 10 46 0.2× 13 0.0× 315 3.9× 47 0.7× 5 0.1× 12 449
José J. Escobar Colombia 5 19 0.1× 14 0.1× 32 0.4× 45 0.6× 5 0.1× 15 189
N Akamatsu Japan 11 48 0.2× 7 0.0× 66 0.8× 19 0.3× 18 0.5× 21 316

Countries citing papers authored by Daniel Aliseda

Since Specialization
Citations

This map shows the geographic impact of Daniel Aliseda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Aliseda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Aliseda more than expected).

Fields of papers citing papers by Daniel Aliseda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Aliseda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Aliseda. The network helps show where Daniel Aliseda may publish in the future.

Co-authorship network of co-authors of Daniel Aliseda

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Aliseda. A scholar is included among the top collaborators of Daniel Aliseda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Aliseda. Daniel Aliseda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aliseda, Daniel, Jorge Arredondo, Javier Rodríguez, et al.. (2024). Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis. British journal of surgery. 111(2). 6 indexed citations
2.
Aliseda, Daniel, Gabriel Zozaya, Pablo Martí‐Cruchaga, et al.. (2024). The impact of portal hypertension assessment method on the outcomes of hepatocellular carcinoma resection: a meta-analysis of matched cohort and prospective studies. HPB. 26. S59–S59. 6 indexed citations
3.
Li, Zhihao, Daniel Aliseda, Owen Jones, et al.. (2024). Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data. JHEP Reports. 7(3). 101290–101290. 3 indexed citations
4.
Ciria, Rubén, Tommy Ivanics, Daniel Aliseda, et al.. (2024). Liver transplantation for primary and secondary liver tumors: Patient-level meta-analyses compared to UNOS conventional indications. Hepatology. 81(6). 1700–1713. 2 indexed citations
5.
Aliseda, Daniel, et al.. (2024). 288P Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis. Annals of Oncology. 35. S121–S122. 2 indexed citations
6.
Berardi, Giammauro, Edoardo Maria Muttillo, Daniel Aliseda, et al.. (2024). Anatomic Versus Non-anatomic Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-Analysis. Annals of Surgical Oncology. 31(13). 9170–9182.
7.
Aliseda, Daniel, Pablo Martí‐Cruchaga, Gabriel Zozaya, et al.. (2024). Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials. BJS Open. 8(5). 7 indexed citations
8.
Aliseda, Daniel, Gonzalo Sapisochín, Pablo Martí‐Cruchaga, et al.. (2023). Association of Laparoscopic Surgery with Improved Perioperative and Survival Outcomes in Patients with Resectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis from Propensity-Score Matched Studies. Annals of Surgical Oncology. 30(8). 4888–4901. 11 indexed citations
9.
Aliseda, Daniel, Pablo Martí‐Cruchaga, Gabriel Zozaya, et al.. (2023). Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience. Cancers. 15(3). 733–733. 12 indexed citations
11.
Aliseda, Daniel, et al.. (2023). Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertension. BJS Open. 7(2). 5 indexed citations
12.
Aliseda, Daniel, Pablo Martí‐Cruchaga, Gabriel Zozaya, et al.. (2022). Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes. Langenbeck s Archives of Surgery. 407(3). 1099–1111. 1 indexed citations
14.
Cienfuegos, Javier A., et al.. (2021). Etiopatogenia de neumoperitoneo en pacientes COVID-19. Cirugía Española. 99(6). 476–477.
15.
Valentí, Víctor, et al.. (2020). Severe colon ischemia in patients with severe coronavirus-19 (COVID-19). Revista Española de Enfermedades Digestivas. 112(10). 784–787. 15 indexed citations
16.
Serrano, Luís, et al.. (2012). Diabetic retinopathy screening with non-mydriatic retinography by general practitioners: 2-Year results. Primary care diabetes. 6(3). 201–205. 20 indexed citations
18.
Moreno‐Montañés, Javier, et al.. (1999). Final clear corneal incision size for AcrySof intraocular lenses. Journal of Cataract & Refractive Surgery. 25(7). 959–963. 14 indexed citations
19.
Moreno‐Montañés, Javier, et al.. (1998). Variation in clear cornea incision size after phacoemulsification and foldable lens implantation. Journal of Cataract & Refractive Surgery. 24(7). 931–934. 12 indexed citations
20.
Aliseda, Daniel, et al.. (1997). Medial Canthus Tumor Surgery: A Prospective Study of Microscopically Controlled Excision. European Journal of Ophthalmology. 7(3). 216–222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026